retatrutide + cagrilintide vs retatrutide: amylin analogue vs triple agonist compared Reta/Cagri Blend – 12.5mg/2.5mg |

A reasonable candidate is someone who: Is already following a structured, clinician-supervised nutrition and activity plan Has a documented B12 deficiency or a condition that impairs B12 absorption Cannot tolerate GLP-1 medications, or is not a candidate for them Declines prescription pharmacotherapy and wants a non-stimulant, non-surgical adjunct Understands because the clinician has said so plainly that the injection is a supporting player A poor candidate is someone who wants the shot instead of the program

Limitations and Ongoing Research Despite promising observations, it is important to note that most research on BPC-157 remains preclinical

Miller, Wilbur R

Keep your doctor informed about your overall health condition and any other medications you may be taking